Fusions involving the neurotrophin receptor tyrosine kinase genes (NTRK1, NTRK2, and NTRK3) recur in cancers like gliomas, secretory breast cancer, and lung cancer (112). This evidence concerns the gene NTRK3 and lung carcinoma.